McCoy, R. G., Dykhoff, H. J., Sangaralingham, L., Ross, J. S., Karaca-Mandic, P., Montori, V. M., & Shah, N. D. (2019). Adoption of New Glucose-Lowering Medications in the U.S.—The Case of SGLT2 Inhibitors: Nationwide Cohort Study. Diabetes Technol Ther.
Chicago ZitierstilMcCoy, Rozalina G., Hayley J. Dykhoff, Lindsey Sangaralingham, Joseph S. Ross, Pinar Karaca-Mandic, Victor M. Montori, und Nilay D. Shah. "Adoption of New Glucose-Lowering Medications in the U.S.—The Case of SGLT2 Inhibitors: Nationwide Cohort Study." Diabetes Technol Ther 2019.
MLA ZitierstilMcCoy, Rozalina G., et al. "Adoption of New Glucose-Lowering Medications in the U.S.—The Case of SGLT2 Inhibitors: Nationwide Cohort Study." Diabetes Technol Ther 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.